𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Granulocyte-macrophage colony-stimulating factor inhalation therapy for patients with idiopathic pulmonary alveolar proteinosis: a pilot study; and long-term treatment with aerosolized granulocyte-macrophage colony-stimulating factor: a case report

✍ Scribed by Ryushi TAZAWA; Koh NAKATA; Yoshikazu INOUE; Toshihiro NUKIWA


Book ID
108964419
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
155 KB
Volume
11
Category
Article
ISSN
1323-7799

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Short term treatment with Escheria coli
✍ M. Aglietta; F. Montemurro; F. Fagioli; C. Volta; B. Botto; M. Cantonetti; V. Ra πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 89 KB πŸ‘ 1 views

## BACKGROUND. Granulocyte-macrophage-colony stimulating factor (GM-CSF) administration stimulates the proliferation of hemopoietic progenitors. Shortly (48 -96 hours) after its discontinuation, feedback phenomena occur and the progenitor proliferation rate drops below baseline levels. As the quies

A Phase Ib/II trial of granulocyte-macro
✍ Kirsten M. Hotton; Masoud Khorsand; Jacquelyn A. Hank; Mark Albertini; Kyung Man πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 187 KB πŸ‘ 2 views

## BACKGROUND. Interleukin-2 (IL-2) and granulocyte-macrophageΟͺcolony stimulating factor (GM-CSF) are cytokines with nonoverlapping pleiotropic effects. In a prior Phase Ib study, this combination of agents exhibited antitumor effects in the lungs of four of eight patients with renal cell carcinoma